UTAK Pain Management PM 100
Lyophilized whole blood toxicology control for the quantitative determination of Pain management drugs and their metabolites adjusted depending on the analyte to: 100 ng/ml or 10 ng/ml
100 % human whole blood matrix
Norbuprenorphine, Codeine, Fentanyl, Norfentanyl, Hydrocodone, Hydromorphone, Meperidine, Methadone, Methadone Primary Metabolite (EDDP), Morphine, Oxycodone, Oxymorphone, Tapentadol, Tramadol
Analyte composition and analyte concentration may vary with each LOT or instrument. Refer to the package insert of currently available lots for specific analyte and stability claims.
Instrument specific values for:
GC-MS, LC-MS, LC-MS/MS, EMIT, CEDIA
UTAK REF 21080 PM 100 (Pain Management) (WB) 5 x 5 ml
30 month at 2…8 °C
25 days at 2…8 °C
Safety data sheet (SDS):
An actual instruction for use is available under Download. Access to the download area with your login.